Literature DB >> 5104070

Immunosuppression by platinum diamines.

M C Berenbaum.   

Abstract

Platinum diamine dichloride and tetrachloride inhibit the formation of antibody-forming cells in the mouse spleen after injection of sheep red cells. The dichloride is the more effective agent. It acts best when given 2 days after the antigen, which suggests that cells are more sensitive to its action when they are rapidly proliferating than when they are resting. Its dose-response curve is exponential, suggesting that its action is like that of an alkylating agent. Platinum ethylene diamines were relatively ineffective in this system.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5104070      PMCID: PMC2008537          DOI: 10.1038/bjc.1971.27

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  4 in total

1.  The successful regression of large solid sarcoma 180 tumors by platinum compounds.

Authors:  B Rosenberg; L VanCamp
Journal:  Cancer Res       Date:  1970-06       Impact factor: 12.701

2.  The inhibition of growth or cell division in Escherichia coli by different ionic species of platinum(IV) complexes.

Authors:  B Rosenberg; L Van Camp; E B Grimley; A J Thomson
Journal:  J Biol Chem       Date:  1967-03-25       Impact factor: 5.157

3.  Platinum compounds: a new class of potent antitumour agents.

Authors:  B Rosenberg; L VanCamp; J E Trosko; V H Mansour
Journal:  Nature       Date:  1969-04-26       Impact factor: 49.962

4.  Dose-response curves for agents that impair cell reproductive integrity. A fundamental difference between dose-response curves of antimetabolites and those for radiation and alkylating agents.

Authors:  M C Berenbaum
Journal:  Br J Cancer       Date:  1969-06       Impact factor: 7.640

  4 in total
  3 in total

1.  Low level chromium (VI) inhalation effects on alveolar macrophages and immune functions in Wistar rats.

Authors:  U Glaser; D Hochrainer; H Klöppel; H Kuhnen
Journal:  Arch Toxicol       Date:  1985-09       Impact factor: 5.153

Review 2.  In vitro assessment of humoral immunity following exposure to heavy metals.

Authors:  L D Koller
Journal:  Environ Health Perspect       Date:  1982-02       Impact factor: 9.031

3.  Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1-Deficient Thoracic Cancers.

Authors:  Emma Beddowes; James Spicer; Pui Ying Chan; Ramsay Khadeir; Javier Garcia Corbacho; Dimitra Repana; Jeremy P Steele; Peter Schmid; Teresa Szyszko; Gary Cook; Monica Diaz; Xiaoxing Feng; Amanda Johnston; Jim Thomson; Michael Sheaff; Bor-Wen Wu; John Bomalaski; Simon Pacey; Peter W Szlosarek
Journal:  J Clin Oncol       Date:  2017-04-07       Impact factor: 44.544

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.